Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio Pricing

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Financials - StockMarketCap

Stocks›Mabwell (Shanghai) Bioscience Co., Ltd.☆

● At closeAs of Jul 6, 2026

Mabwell (Shanghai) Bioscience Co., Ltd.

SHA: 688062✓

HealthcareBiotechnologySHH

$4.99CN¥33.88+5.68%

$1.99BMarket cap

-P/E ratio

22.48MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$4.99CN¥33.88

$0.27 (+5.68%) · 24h

Key metrics

Market cap$1.99B+30.76%

Enterprise value$1.99B

Volume (24h)22.48M

P/E ratio (TTM)-

P/S ratio (TTM)-

Dividend yield-

Shares outstanding399.60M

Trading range

Previous closeCN¥32.06

Day rangeCN¥31.60 - CN¥36.50

52-week range-

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) operates in the Biotechnology industry within the Healthcare sector, listed on SHH.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG-1.61%

Merck & Co., Inc.+3.31%

Financial statements coming soon for Mabwell (Shanghai) Bioscience Co., Ltd..